The Latest Breaking News from Omicron

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Intellia Therapeutics’ (NASDAQ:NTLA) lead asset NTLA-2002, for the treatment of hereditary angioedema (HAE). Intellia shares traded in a range of $56.52 to $60.06 on day volume of 901.43 thousand shares, closed regular trading session at $59.97. The company…

CDC Director Rochelle Walensky has signed off on updated versions of the Moderna and Pfizer-BioNTech vaccines that target the original virus and the omicron subvariants.

On Sept. 1, 2022, the Centers for Disease Control and Prevention endorsed the use of updated COVID-19 booster shots that are specifically tailored to combat the two most prevalent omicron subvariants, BA.4 and BA.5. The decision comes just a day after the Food and Drug Administration’s emergency use authorization of…

Experts answer some top questions about Omicron-specific COVID boosters.

Fainting and fatigue may signal onset of variant, experts say

Around one in five vaccinated Britons with Omicron or Delta strain experienced diarrhoea as a symptom

UK hit by fifth wave of infections earlier this summer driven by new Omicron variants

Mandatory face masks on Victorian public transport are here to stay, but the state's work from home recommendation has been lifted.

The FDA today authorized the new booster, which could arrive as early as next week in Chicago, where nearly 2 million residents are expected to be eligible.